166 related articles for article (PubMed ID: 38488467)
21. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
[TBL] [Abstract][Full Text] [Related]
22. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
Yorgason JT; Hedges DM; Obray JD; Jang EY; Bills KB; Woodbury M; Williams B; Parsons MJ; Andres MA; Steffensen SC
Psychopharmacology (Berl); 2020 May; 237(5):1317-1330. PubMed ID: 31965252
[TBL] [Abstract][Full Text] [Related]
23. Absence of methamphetamine-induced conditioned place preference in weaver mutant mice.
Ikekubo Y; Ide S; Hagino Y; Ikeda K
Neuropsychopharmacol Rep; 2020 Dec; 40(4):324-331. PubMed ID: 32812711
[TBL] [Abstract][Full Text] [Related]
24. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
Baracz SJ; Everett NA; McGregor IS; Cornish JL
Addict Biol; 2016 Mar; 21(2):316-25. PubMed ID: 25399704
[TBL] [Abstract][Full Text] [Related]
25. The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.
Jang EY; Yang CH; Hedges DM; Kim SP; Lee JY; Ekins TG; Garcia BT; Kim HY; Nelson AC; Kim NJ; Steffensen SC
Addict Biol; 2017 Sep; 22(5):1304-1315. PubMed ID: 27417190
[TBL] [Abstract][Full Text] [Related]
26. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
[TBL] [Abstract][Full Text] [Related]
27. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference.
Baracz SJ; Rourke PI; Pardey MC; Hunt GE; McGregor IS; Cornish JL
Behav Brain Res; 2012 Mar; 228(1):185-93. PubMed ID: 22155611
[TBL] [Abstract][Full Text] [Related]
28. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
Sun L; Song R; Chen Y; Yang RF; Wu N; Su RB; Li J
Acta Pharmacol Sin; 2016 Feb; 37(2):157-65. PubMed ID: 26687935
[TBL] [Abstract][Full Text] [Related]
29. A novel microRNA, novel-m009C, regulates methamphetamine rewarding effects.
Zhu L; Wu F; Yan Z; He L; Wang S; Hu H; Goh ELK; Zhu Y; Guan F; Chen T
Mol Psychiatry; 2022 Sep; 27(9):3885-3897. PubMed ID: 35715487
[TBL] [Abstract][Full Text] [Related]
30. Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling.
Wang J; Liang M; Shang Q; Qian H; An R; Liu H; Shao G; Li T; Liu X
CNS Neurosci Ther; 2023 Mar; 29(3):831-841. PubMed ID: 36627756
[TBL] [Abstract][Full Text] [Related]
31. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region.
Hassanlou AA; Jamali S; RayatSanati K; Mousavi Z; Haghparast A
Brain Res Bull; 2021 Jul; 172():43-51. PubMed ID: 33862125
[TBL] [Abstract][Full Text] [Related]
32. Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders.
Kang S; Dahl R; Hsieh W; Shin A; Zsebo KM; Buettner C; Hajjar RJ; Lebeche D
J Biol Chem; 2016 Mar; 291(10):5185-98. PubMed ID: 26702054
[TBL] [Abstract][Full Text] [Related]
33. Neural Circuits Associated with 5-HT
Der-Ghazarian TS; Charmchi D; Noudali SN; Scott SN; Holter MC; Newbern JM; Neisewander JL
ACS Chem Neurosci; 2019 Jul; 10(7):3271-3283. PubMed ID: 31042352
[TBL] [Abstract][Full Text] [Related]
34. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.
Niwa M; Nitta A; Mizoguchi H; Ito Y; Noda Y; Nagai T; Nabeshima T
J Neurosci; 2007 Jul; 27(28):7604-15. PubMed ID: 17626222
[TBL] [Abstract][Full Text] [Related]
35. Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.
Kim NJ; Ryu Y; Lee BH; Chang S; Fan Y; Gwak YS; Yang CH; Bills KB; Steffensen SC; Koo JS; Jang EY; Kim HY
Addict Biol; 2019 Mar; 24(2):206-217. PubMed ID: 29363229
[TBL] [Abstract][Full Text] [Related]
36. Sodium butyrate modulates a methamphetamine-induced conditioned place preference.
Zhu J; Zhao N; Chen Y; Zhu L; Zhong Q; Liu J; Chen T
J Neurosci Res; 2017 Apr; 95(4):1044-1052. PubMed ID: 27426635
[TBL] [Abstract][Full Text] [Related]
37. Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine.
Horio M; Kohno M; Fujita Y; Ishima T; Inoue R; Mori H; Hashimoto K
PLoS One; 2012; 7(4):e35494. PubMed ID: 22530033
[TBL] [Abstract][Full Text] [Related]
38. Blockade of TRPV1 Inhibits Methamphetamine-induced Rewarding Effects.
Tian YH; Ma SX; Lee KW; Wee S; Koob GF; Lee SY; Jang CG
Sci Rep; 2018 Jan; 8(1):882. PubMed ID: 29343767
[TBL] [Abstract][Full Text] [Related]
39. Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex.
Haddar M; Uno K; Hamatani K; Muramatsu SI; Nitta A
Neuropsychopharmacol Rep; 2019 Sep; 39(3):209-216. PubMed ID: 31283871
[TBL] [Abstract][Full Text] [Related]
40. The effect of protein phosphatase 2A inhibitor LB100 on regulating methamphetamine induced conditioned place preference in mice.
Qian H; Wang J; Shang Q; Xiao J; Chen G; Gao B; Liang M; Li T; Liu X
Neurosci Lett; 2020 Mar; 721():134817. PubMed ID: 32032748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
